Radiopharmaceutical diagnosis of Erdheim-Chester's disease.
Erdheim-Chester's disease is a non-inherited multi-focal lipid-storing histiocytosis of unknown origin without a complete and convincing diagnostic and therapeutic protocol. We have previously suggested diagnostic methods using radioisotopes to evaluate this disseminating disease, but they are neither specific nor selective in this regard. The present hypothesis-driven paper reviewing our case proposes novel approaches involving nuclear medicine and utilizing radiopharmaceuticals to identify this potentially fatal multi-system disease.
Palotás
András
A
Division of Cardiac Center for Cardiology Department of Psychiatry, Asklepios-Med Bt., H-6722 Szeged, Kossuth Lajos sgt. 23, Hungary. palotas@nepsy.szote.u-szeged.hu
Bogáts
Gábor
G
Lázár
Máté
M
Papós
Miklós
M
Matin
Keyvan
K
Pávics
László
L
D001842:Bone and Bones / Q000000981:diagnostic imaging; D031249:Erdheim-Chester Disease / Q000175:diagnosis* / Q000000981:diagnostic imaging*; D006098:Granulocytes / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D009943:Organophosphorus Compounds / Q000494:pharmacology; D015609:Organotechnetium Compounds / Q000494:pharmacology; D019275:Radiopharmaceuticals; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods; D051598:Whole Body Imaging
D009943:Organophosphorus Compounds; D015609:Organotechnetium Compounds; D019275:Radiopharmaceuticals; C078700:technetium tc-99m tetrofosmin